Screener
Revvity RVTY Life Sciences — Segment revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Revvity’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000031791-26-000019
| Line item | Reportable Segments / Three Months Ended / April 5, 2026 / Life Sciences | Reportable Segments / Three Months Ended / April 5, 2026 / Diagnostics | Reportable Segments / Three Months Ended / April 5, 2026 / Total | Reportable Segments / Three Months Ended / March 30, 2025 / Life Sciences | Reportable Segments / Three Months Ended / March 30, 2025 / Diagnostics | Reportable Segments / Three Months Ended / March 30, 2025 / Total |
|---|---|---|---|---|---|---|
| Americas | $185,551 | $130,441 | $315,992 | $184,279 | $120,350 | $304,629 |
| Europe | 91,695 | 131,351 | 223,046 | 76,022 | 105,770 | 181,792 |
| Asia | 84,599 | 87,481 | 172,080 | 80,094 | 98,247 | 178,341 |
| $361,845 | $349,273 | $711,118 | $340,395 | $324,367 | $664,762 | |
| Major goods/service lines | ||||||
| Life Sciences Solutions | $299,996 | — | $299,996 | $286,453 | — | $286,453 |
| Software | 61,849 | — | 61,849 | 53,942 | — | 53,942 |
| Immunodiagnostics | — | 201,831 | 201,831 | — | 197,562 | 197,562 |
Item 1.Unaudited Financial Statements
FAQ
- What is Revvity's life sciences — segment revenue?
- Revvity (RVTY) reported life sciences — segment revenue of $361.85M in Q1 2026.
- How has Revvity's life sciences — segment revenue changed year-over-year?
- Revvity's life sciences — segment revenue increased by 6.3% year-over-year, from $340.4M to $361.85M.
- What is the long-term trend for Revvity's life sciences — segment revenue?
- Over 3 years (2022 to 2025), Revvity's life sciences — segment revenue has grown at a 3.4% compound annual growth rate (CAGR), from $1.29B to $1.43B.
- What does life sciences — segment revenue mean?
- Represents the total gross revenue generated by the Life Sciences business segment from the sale of products, services, and software solutions. This metric reflects the market demand and commercial success of the segment's portfolio within the pharmaceutical and biomedical industries.
Ask your AI about Revvity's life sciences — segment revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude